Flyover Capital

Founded in 2019, TripleBlind operates an online platform enabling entities to collaborate on sensitive data and algorithms without compromising privacy. Its software-only solution, delivered via API, focuses on healthcare and financial services, supporting various data types and cloud platforms. Backed by Accenture, General Catalyst, and Mayo Clinic, TripleBlind ensures compliance with HIPAA and GDPR.

Founded in 2019, TripleBlind operates an online platform enabling entities to collaborate on sensitive data and algorithms without compromising privacy. Its software-only solution, delivered via API, focuses on healthcare and financial services, supporting various data types and cloud platforms. Backed by Accenture, General Catalyst, and Mayo Clinic, TripleBlind ensures compliance with HIPAA and GDPR.

EyeVerify Inc. is a biometric technology company based in Kansas City, Missouri, founded in 2012. It specializes in eye-based biometric solutions for mobile devices, offering its primary product, EyePrint ID. This patented authentication solution utilizes existing smartphone cameras to capture and analyze the unique patterns of blood vessels in the eye, providing a secure and password-free mobile experience. EyePrint ID is designed to enhance data security with an encryption key equivalent to a complex 50-character password, making it suitable for use on both iOS and Android platforms. The company primarily serves businesses looking to secure customer data through its innovative biometric verification technology. As of September 2016, EyeVerify operates as a subsidiary of Ant Financial Services Group.

Innara Health, Inc. is a company focused on developing innovative neonatal care technologies aimed at improving the health and development of preterm and full-term infants, as well as children with developmental needs. The company is best known for its NTrainer System, a medical device designed to assist with the feeding of premature infants by promoting non-nutritive sucking skills and enhancing feeding outcomes. This device plays a crucial role in developmental feeding programs, allowing infants to engage in early and frequent nipping opportunities that help coordinate their suck, swallow, and breathe functions. Innara Health serves a wide range of stakeholders, including hospitals, neonatal intensive care units, clinicians, infants, children, and their families, with the goal of improving the quality of life for these vulnerable populations. Founded in 2006 and based in Olathe, Kansas, the company was previously known as KCBioMedix, Inc. before rebranding in 2013.